These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 18245489

  • 1. Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion.
    Montes CL, Chapoval AI, Nelson J, Orhue V, Zhang X, Schulze DH, Strome SE, Gastman BR.
    Cancer Res; 2008 Feb 01; 68(3):870-9. PubMed ID: 18245489
    [Abstract] [Full Text] [Related]

  • 2. Novel mechanisms of suppressor activity exhibited by cytotoxic regulatory T cell lines, HOZOT.
    Suzuki M, Sugimoto A, Harashima A, Otani T, Yamamoto M, Nakamura S, Yamasaki F, Nishiyama M, Okazaki Y, Kibata M.
    Exp Hematol; 2009 Jan 01; 37(1):92-100. PubMed ID: 19013006
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The significance of Treg cells in defective tumor immunity.
    Kosmaczewska A, Ciszak L, Potoczek S, Frydecka I.
    Arch Immunol Ther Exp (Warsz); 2008 Jan 01; 56(3):181-91. PubMed ID: 18512029
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Replicative senescence of CD8 T cells: effect on human ageing.
    Effros RB.
    Exp Gerontol; 2004 Apr 01; 39(4):517-24. PubMed ID: 15050285
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.
    Attig S, Hennenlotter J, Pawelec G, Klein G, Koch SD, Pircher H, Feyerabend S, Wernet D, Stenzl A, Rammensee HG, Gouttefangeas C.
    Cancer Res; 2009 Nov 01; 69(21):8412-9. PubMed ID: 19843860
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effector/memory but not naive regulatory T cells are responsible for the loss of concomitant tumor immunity.
    Lin YC, Chang LY, Huang CT, Peng HM, Dutta A, Chen TC, Yeh CT, Lin CY.
    J Immunol; 2009 May 15; 182(10):6095-104. PubMed ID: 19414761
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
    Hoskin DW, Mader JS, Furlong SJ, Conrad DM, Blay J.
    Int J Oncol; 2008 Mar 15; 32(3):527-35. PubMed ID: 18292929
    [Abstract] [Full Text] [Related]

  • 12. Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2.
    Svane IM, Pedersen AE, Nikolajsen K, Zocca MB.
    Vaccine; 2008 Aug 26; 26(36):4716-24. PubMed ID: 18616968
    [Abstract] [Full Text] [Related]

  • 13. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
    Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V.
    Immunol Rev; 2008 Apr 26; 222():162-79. PubMed ID: 18364001
    [Abstract] [Full Text] [Related]

  • 14. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
    Liu Q, Zhang C, Sun A, Zheng Y, Wang L, Cao X.
    J Immunol; 2009 May 15; 182(10):6207-16. PubMed ID: 19414774
    [Abstract] [Full Text] [Related]

  • 15. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
    Wang RF.
    Hum Immunol; 2008 Nov 15; 69(11):811-4. PubMed ID: 18817828
    [Abstract] [Full Text] [Related]

  • 16. Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells.
    Fenoglio D, Ferrera F, Fravega M, Balestra P, Battaglia F, Proietti M, Andrei C, Olive D, Antonio LC, Indiveri F, Filaci G.
    Hum Immunol; 2008 Nov 15; 69(11):745-50. PubMed ID: 18832002
    [Abstract] [Full Text] [Related]

  • 17. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M, Henjum K, Yaqub S, Bjørnbeth BA, Torgersen KM, Taskén K, Aandahl EM.
    Eur J Immunol; 2008 Mar 15; 38(3):640-6. PubMed ID: 18266270
    [Abstract] [Full Text] [Related]

  • 18. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH, Chiang YH, Chang SE, Chong CL, Cheng BM, Roffler SR.
    Clin Cancer Res; 2009 Apr 15; 15(8):2756-66. PubMed ID: 19318495
    [Abstract] [Full Text] [Related]

  • 19. A novel vicious cycle cascade in tumor chemotherapy.
    Zhou H, Zou P, Chen ZC, You Y.
    Med Hypotheses; 2007 Apr 15; 69(6):1230-3. PubMed ID: 17555885
    [Abstract] [Full Text] [Related]

  • 20. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.
    Maccalli C, Di Cristanziano V, Fodale V, Corsi D, D'Agostino G, Petrangeli V, Laurenti L, Guida S, Mazzocchi A, Arienti F, Perrone MP, Castelli C, Rivoltini L, Zagonel V, Tartaglia M, Parmiani G, Belardelli F.
    Clin Cancer Res; 2008 Nov 15; 14(22):7292-303. PubMed ID: 18974390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.